skip to content
CMS Buy Now
Detailed Quote
5i Report
Rating
B+

Review of Savaria

JUL 15, 2019 - Accessibility and medical product provider facing some cost issues after completing significant acquisitions. Rating maintained at 'B+'.

Download Report
Company Profile
Interactive Chart
Key Ratios
Top Banner 5i Free Trial
Earnings
Analyst Recommendations
5i Recent Questions

Q: I hold the above stocks in my portfolio. Thinking of adding QSR. Your thoughts. Or should I keep my cash for better opportunities during tax loss period ? BEW and PNG are my play money. Playing PNG with house money.

Read Answer Asked by Roy on September 12, 2019
Insiders
https://research-5iresearch.lpages.co/free-trial-5i-research-5i-blog/
Share Information
News and Media